Literature DB >> 12512843

Atypical presentations of thrombotic thrombocytopenic purpura.

Timothy E O'Brien1, Edward D Crum.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) usually presents in a fulminant fashion with marked hematologic abnormalities often associated with fever and neurologic and renal abnormalities. Two cases of TTP are reported in which neurologic deficits were initially the dominant findings, followed weeks later by the pronounced hematologic manifestations. Young patients with unexplained neurologic findings, even if there is only minimal anemia or thrombocytopenia, should be monitored for subsequent manifestations of TTP so that treatment may be instituted promptly.

Entities:  

Mesh:

Year:  2002        PMID: 12512843     DOI: 10.1007/bf02982814

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

1.  Thrombotic thrombocytopenic purpura.

Authors:  W Bell
Journal:  JAMA       Date:  1991-01-02       Impact factor: 56.272

Review 2.  Chronic relapsing thrombotic thrombocytopenic purpura and antiphospholipid antibodies: a report of two cases.

Authors:  K Trent; B R Neustater; R Lottenberg
Journal:  Am J Hematol       Date:  1997-02       Impact factor: 10.047

3.  High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients.

Authors:  M Rose; A Eldor
Journal:  Am J Med       Date:  1987-09       Impact factor: 4.965

Review 4.  Platelet secretory products may contribute to neuronal injury.

Authors:  R Joseph; C Tsering; S Grunfeld; K M Welch
Journal:  Stroke       Date:  1991-11       Impact factor: 7.914

5.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-1994. A 41-year-old woman with thrombocytopenia, anemia, and sudden death.

Authors: 
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245

6.  Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

Authors:  G A Rock; K H Shumak; N A Buskard; V S Blanchette; J G Kelton; R C Nair; R A Spasoff
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

7.  Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.

Authors:  W R Bell; H G Braine; P M Ness; T S Kickler
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

Review 8.  Prognostic significance of computed tomography of the brain in thrombotic thrombocytopenic purpura.

Authors:  A C Kay; L A Solberg; D A Nichols; R M Petitt
Journal:  Mayo Clin Proc       Date:  1991-06       Impact factor: 7.616

9.  Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases.

Authors:  C L Bennett; P D Weinberg; K Rozenberg-Ben-Dror; P R Yarnold; H C Kwaan; D Green
Journal:  Ann Intern Med       Date:  1998-04-01       Impact factor: 25.391

10.  Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.

Authors:  H M Tsai; E C Lian
Journal:  N Engl J Med       Date:  1998-11-26       Impact factor: 91.245

View more
  4 in total

1.  Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.

Authors:  Yosef Kalish; Amihai Rottenstreich; Deborah Rund; Sarit Hochberg-Klein
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

2.  Pearls and oy-sters: acute ischemic stroke caused by atypical thrombotic thrombocytopenic purpura.

Authors:  Julio C Rojas; Chirantan Banerjee; Fazeel Siddiqui; Bardia Nourbakhsh; Craig M Powell
Journal:  Neurology       Date:  2013-05-28       Impact factor: 9.910

3.  A Case of Thrombotic Thrombocytopenic Purpura without Pathognomonic Schistocytes.

Authors:  Kevin Yu; Min Yan
Journal:  Clin Pract       Date:  2021-04-13

4.  Thrombotic Thrombocytopenic Purpura Masquerading as Acute Ischemic Stroke.

Authors:  Asia Filatov; Emily Kassar; Oladipo Cole
Journal:  Cureus       Date:  2020-04-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.